1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Jordan Pharmaceuticals and Healthcare Report Q1 2016

Jordan Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 97 pages

BMI View

: Jordan offers an attractive pharmaceutical market for multinational drugmakers, although itspotential will remain impeded by the ongoing political and economic instability in neighbouring Syria -which is having a detrimental impact on Jordan's healthcare sector.

Headline Expenditure Projections

- Pharmaceuticals: JOD643mn (USD905mn) in 2014 to JOD683mn (USD962mn) in 2015; +6.3% inlocal currency terms and US dollar terms. Forecast unchanged from Q415.

- Healthcare: JOD1.86bn (USD2.62bn) in 2014 to JOD1.97bn (USD2.78bn) in 2015; +6.2% in localcurrency terms and US dollar terms. Forecast in line with Q415.

Table Of Contents

Jordan Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Jordan 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Jordan 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Jordan 2011-2019) 15
Prescription Drug Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 21
OTC Medicine Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Jordan 2011-2019) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Jordan 2013-2019) 26
Table: Pharmaceutical Trade Data And Forecasts local currency (Jordan 2013-2019) 26
Industry Risk/Reward Index 27
Middle East and Africa Risk/Reward Index - Q1 2016 27
Jordan Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Regulatory Developments 38
Intellectual Property Issues 39
Pricing And Reimbursement Regime 42
Market Overview 46
Healthcare Sector 47
Healthcare Insurance 49
Table: Healthcare Resources (Jordan 2009-2014) 54
Table: Healthcare Personnel (Jordan 2009-2014) 54
Table: Healthcare Activity (Jordan 2009-2014) 55
Research and Development 55
Clinical Trials 57
Epidemiology 59
Competitive Landscape 61
Research-Based Industry 61
Table: Multinational Company Activity 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 66
Company Profile 68
Dar al-Dawa 68
Hikma Pharmaceuticals 71
Jordanian Pharmaceutical Manufacturing Company (JPM) 77
Pharma International Company 80
United Pharmaceutical Manufacturers 83
Demographic Forecast 86
Jordan Demographic Forecast 86
Table: Population Headline Indicators (Jordan 1990-2025) 87
Table: Key Population Ratios (Jordan 1990-2025) 87
Table: Urban/Rural Population and Life Expectancy (Jordan 1990-2025) 88
Table: Population By Age Group (Jordan 1990-2025) 88
Table: Population By Age Group % (Jordan 1990-2025) 89
Glossary 91
Methodology 93
Pharmaceutical Expenditure Forecast Model 93
Healthcare Expenditure Forecast Model 93
Notes On Methodology 94
Risk/Reward Index Methodology 95
Index Overview 96
Table: Pharmaceutical Risk/Reward Index Indicators 96
Indicator Weightings 97

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.